• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸切除术后血清碱性磷酸酶活性升高:前列腺癌无进展生存期的一个有价值的不良预后指标。

The flare in serum alkaline phosphatase activity after orchiectomy: a valuable negative prognostic index for progression-free survival in prostatic carcinoma.

作者信息

Pelger R C, Lycklama A Nijeholt G A, Zwinderman A H, Papapoulos S E, Hamdy N A

机构信息

Department of Urology, University Hospital, Leiden, The Netherlands.

出版信息

J Urol. 1996 Jul;156(1):122-6. doi: 10.1016/s0022-5347(01)65962-7.

DOI:10.1016/s0022-5347(01)65962-7
PMID:8648772
Abstract

PURPOSE

We determined whether an early flare in serum alkaline phosphatase activity after orchiectomy was of prognostic value for progression-free survival in patients with advanced prostatic carcinoma.

MATERIALS AND METHODS

A retrospective analysis of a data base from a Dutch multicenter study on prostatic carcinoma was done to determine the prognostic value of a flare in alkaline phosphatase activity after orchiectomy in 112 patients with metastatic (75%) or locally advanced (25%) disease. Cox's proportional hazards models and Kaplan-Meier survival curves were used.

RESULTS

Of the patients 50% had initially increased alkaline phosphatase levels and a flare in activity was demonstrated in 87% 2 to 4 weeks after orchiectomy. The prostate specific antigen nadir (cutoff 4 ng./ml.) 6 months after orchiectomy was of significant prognostic value for progression-free survival. A flare in alkaline phosphatase activity after orchiectomy demonstrated an early significant prognostic value for progression-free survival, independent of the serum alkaline phosphatase activity.

CONCLUSIONS

The simplicity, ready availability and cost-effectiveness of serum alkaline phosphatase activity as a prognostic index render it attractive to the clinician, particularly early in the course of prostatic carcinoma. Measuring the flare in alkaline phosphatase activity within 1 month of orchiectomy may permit early identification of patients in whom the disease is likely to progress rapidly and who would potentially benefit from aggressive treatment.

摘要

目的

我们确定睾丸切除术后血清碱性磷酸酶活性早期升高对于晚期前列腺癌患者无进展生存期是否具有预后价值。

材料与方法

对荷兰一项前列腺癌多中心研究的数据库进行回顾性分析,以确定睾丸切除术后碱性磷酸酶活性升高对112例转移性(75%)或局部晚期(25%)疾病患者的预后价值。使用Cox比例风险模型和Kaplan-Meier生存曲线。

结果

50%的患者最初碱性磷酸酶水平升高,87%的患者在睾丸切除术后2至4周出现活性升高。睾丸切除术后6个月前列腺特异性抗原最低点(临界值4 ng/ml)对无进展生存期具有显著预后价值。睾丸切除术后碱性磷酸酶活性升高对无进展生存期具有早期显著预后价值,与血清碱性磷酸酶活性无关。

结论

血清碱性磷酸酶活性作为一种预后指标,其简单性、易获得性和成本效益对临床医生具有吸引力,尤其是在前列腺癌病程早期。在睾丸切除术后1个月内测量碱性磷酸酶活性的升高,可能有助于早期识别疾病可能迅速进展且可能从积极治疗中获益的患者。

相似文献

1
The flare in serum alkaline phosphatase activity after orchiectomy: a valuable negative prognostic index for progression-free survival in prostatic carcinoma.睾丸切除术后血清碱性磷酸酶活性升高:前列腺癌无进展生存期的一个有价值的不良预后指标。
J Urol. 1996 Jul;156(1):122-6. doi: 10.1016/s0022-5347(01)65962-7.
2
The flare in alkaline phosphatase activity post-orchidectomy predicts which patient may benefit from early chemotherapy in metastatic prostate cancer.睾丸切除术后碱性磷酸酶活性的升高预示着哪些转移性前列腺癌患者可能从早期化疗中获益。
Prostate. 2002 Feb 1;50(2):119-24. doi: 10.1002/pros.10040.
3
Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.血清标志物作为前列腺转移性癌激素治疗后反应持续时间和患者生存的预测指标。
J Urol. 1997 Apr;157(4):1329-34.
4
Prognostic value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine therapy.内分泌治疗的转移性前列腺癌患者碱性磷酸酶升高的预后价值
Urology. 2000 Nov 1;56(5):843-7. doi: 10.1016/s0090-4295(00)00755-x.
5
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.内分泌治疗难治性前列腺癌患者的预后因素:单因素和多因素分析,包括前列腺特异性抗原和前列腺酸性磷酸酶的倍增时间
Jpn J Clin Oncol. 1997 Aug;27(4):258-62. doi: 10.1093/jjco/27.4.258.
6
A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy.一种简单的预后模型,涉及前列腺特异性抗原、碱性磷酸酶和白蛋白,用于预测接受雄激素剥夺治疗的患者进展为去势抵抗性前列腺癌所需的时间。
Int Urol Nephrol. 2017 Jan;49(1):61-67. doi: 10.1007/s11255-016-1456-z. Epub 2016 Nov 11.
7
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.基于前列腺特异性抗原和碱性磷酸酶早期系列测量对转移性前列腺癌生存情况的预测
J Urol. 2008 Jan;179(1):117-22; discussion 122-3. doi: 10.1016/j.juro.2007.08.132. Epub 2007 Nov 12.
8
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.非去势转移性前列腺癌生存的预后因素:格拉斯模型的验证和新型简化预后模型的建立。
Eur Urol. 2015 Aug;68(2):196-204. doi: 10.1016/j.eururo.2014.09.022. Epub 2014 Sep 30.
9
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).通过血清碱性磷酸酶活性评估的成骨细胞耀斑是接受全身治疗的前列腺癌骨转移患者短期反应的一个指标。皮埃蒙特肿瘤泌尿学组(G.O.U.P)。
Anticancer Res. 1997 Nov-Dec;17(6D):4697-702.
10
Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.血清骨转换标志物在伴有骨转移的前列腺癌患者中的意义。
Urology. 2010 Jun;75(6):1446-51. doi: 10.1016/j.urology.2009.11.049. Epub 2010 Mar 5.

引用本文的文献

1
Co-Treatment of Purified Annatto Oil ( L.) and Its Granules (Chronic) Improves the Blood Lipid Profile and Bone Protective Effects of Testosterone in the Orchiectomy-Induced Osteoporosis in Wistar Rats.姜黄色素油及其颗粒(慢性)共同治疗可改善去势诱导骨质疏松症 Wistar 大鼠的血脂谱和睾酮的骨保护作用。
Molecules. 2021 Aug 4;26(16):4720. doi: 10.3390/molecules26164720.
2
High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy.一线雄激素剥夺治疗后血清碱性磷酸酶急剧升高预示着接受第二代雄激素受体靶向治疗的转移性前列腺癌患者预后不良。
Prostate Cancer. 2021 Apr 8;2021:5574067. doi: 10.1155/2021/5574067. eCollection 2021.
3
The Alkaline Phosphatase Flare Phenomenon: A Transient Substantial Increase in Alkaline Phosphatase Concentration in a Prostate Cancer Patient after Starting GnRH Agonist Treatment.碱性磷酸酶耀斑现象:一名前列腺癌患者开始GnRH激动剂治疗后碱性磷酸酶浓度的短暂大幅升高。
Case Rep Oncol. 2021 Feb 24;14(1):73-77. doi: 10.1159/000513427. eCollection 2021 Jan-Apr.
4
Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.血清碱性磷酸酶对前列腺癌患者生存的预后价值:一项荟萃分析的证据
Cancer Manag Res. 2018 Aug 30;10:3125-3139. doi: 10.2147/CMAR.S174237. eCollection 2018.
5
Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis.血清碱性磷酸酶可区分去势抵抗性前列腺癌伴骨转移患者 docetaxel 化疗后前列腺特异性抗原flare 与早期疾病进展。
J Cancer Res Clin Oncol. 2014 Oct;140(10):1769-76. doi: 10.1007/s00432-014-1710-7. Epub 2014 May 24.